| X24-05-ZQ670 |
EGFR-HER2 inhibitor Lavendustin A, Purity ≥98%
|
|
| X24-05-ZQ671 |
EGFR-HER2 inhibitor AG-99, Purity ≥98%
|
|
| X24-05-ZQ672 |
EGFR-HER2 inhibitor AG-494, Purity ≥98%
|
|
| X24-05-ZQ673 |
EGFR-HER2 inhibitor Afatinib, Purity ≥98%
|
|
| X24-05-ZQ674 |
EGFR-HER2 inhibitor RG14620, Purity ≥98%
|
|
| X24-05-ZQ675 |
EGFR-HER2 inhibitor AG 555, Purity ≥98%
|
|
| X24-05-ZQ676 |
EGFR-HER2 inhibitor EGFR-IN-7, Purity ≥98%
|
|
| X24-05-ZQ677 |
EGFR-HER2 inhibitor Mutated EGFR-IN-2, Purity ≥98%
|
|
| X24-05-ZQ678 |
EGFR-HER2 inhibitor DBPR112, Purity ≥98%
|
|
| X24-05-ZQ679 |
EGFR-HER2 inhibitor Tarloxotinib bromide, Purity ≥98%
|
|
| X24-05-ZQ680 |
EGFR-HER2 inhibitor Mutant EGFR inhibitor, Purity ≥98%
|
|
| X24-05-ZQ681 |
EGFR-HER2 inhibitor HS-10296 hydrochloride, Purity ≥98%
|
|
| X24-05-ZQ682 |
EGFR-HER2 inhibitor AST2818 mesylate, Purity ≥98%
|
|
| X24-05-ZQ683 |
EGFR-HER2 inhibitor Nazartinib mesylate, Purity ≥98%
|
|
| X24-05-ZQ684 |
EGFR-HER2 inhibitor Nazartinib S-enantiomer, Purity ≥98%
|
|
| X24-05-ZQ685 |
EGFR-HER2 inhibitor Pyrotinib dimaleate, Purity ≥98%
|
|
| X24-05-ZQ686 |
EGFR-HER2 inhibitor Epertinib hydrochloride, Purity ≥98%
|
|
| X24-06-ZQ013 |
EGFR-HER2 inhibitor (Rac)-JBJ-04-125-02, Purity ≥98%
|
|
| X24-06-ZQ014 |
EGFR-HER2 inhibitor AG-1478 hydrochloride, Purity ≥98%
|
|
| X24-06-ZQ015 |
EGFR-HER2 inhibitor AG1557, Purity ≥98%
|
|
| X24-06-ZQ016 |
EGFR-HER2 inhibitor Alflutinib, Purity ≥98%
|
|
| X24-06-ZQ017 |
EGFR-HER2 inhibitor Almonertinib, Purity ≥98%
|
|
| X24-06-ZQ018 |
EGFR-HER2 inhibitor BDTX-189, Purity ≥98%
|
|
| X24-06-ZQ019 |
EGFR-HER2 inhibitor BGB-102, Purity ≥98%
|
|
| X24-06-ZQ020 |
EGFR-HER2 inhibitor BI-4020, Purity ≥98%
|
|
| X24-06-ZQ025 |
EGFR-HER2 inhibitor EGFR-IN-5, Purity ≥98%
|
|
| X24-06-ZQ027 |
EGFR-HER2 inhibitor Mobocertinib, Purity ≥98%
|
|
| X24-06-ZQ028 |
EGFR-HER2 inhibitor Mobocertinib succinate, Purity ≥98%
|
|
| X24-06-ZQ029 |
EGFR-HER2 inhibitor Mutated EGFR-IN-1, Purity ≥98%
|
|
| X24-06-ZQ030 |
EGFR-HER2 inhibitor Naquotinib mesylate, Purity ≥98%
|
|
| X24-06-ZQ032 |
EGFR-HER2 inhibitor NRC-2694, Purity ≥98%
|
|
| X24-06-ZQ033 |
EGFR-HER2 inhibitor Osimertinib dimesylate, Purity ≥98%
|
|
| X24-06-ZQ034 |
EGFR-HER2 inhibitor PD-089828, Purity ≥98%
|
|
| X24-06-ZQ035 |
EGFR-HER2 inhibitor PF-06459988, Purity ≥98%
|
|
| X24-06-ZQ036 |
EGFR-HER2 inhibitor Pyrotinib, Purity ≥98%
|
|
| X24-06-ZQ037 |
EGFR-HER2 inhibitor RTC-5, Purity ≥98%
|
|
| X24-06-ZQ038 |
EGFR-HER2 inhibitor SU5204, Purity ≥98%
|
|
| X24-06-ZQ039 |
EGFR-HER2 inhibitor Theliatinib, Purity ≥98%
|
|
| X24-06-ZQ040 |
EGFR-HER2 inhibitor Zipalertinib, Purity ≥98%
|
|
| X24-08-YM001 |
EGFR-HER2 inhibitor, Lifirafenib, Purity ≥98%
|
|
